Jussi Saukkonen

Jussi Saukkonen is a distinguished professional in the fields of clinical research, clinical trials, and medical technology development with a focus on drug-induced hepatotoxicity and biomarker development. With a specialization in Pulmonary Medicine, Critical Care Medicine, Allergy and Immunology, and Internal Medicine, Jussi has a diverse and extensive background in the medical field.

His educational journey includes fellowships in Pulmonary, Critical Care, and Allergy and Immunology from Boston University Medical Center, an internship, and residency in Internal Medicine from the University of Michigan Hospitals, an MD in Medicine from Jefferson Medical College of Thomas Jefferson University, and a B.S. from Yale University.

Throughout his career, Jussi has taken up various leadership roles such as being the Director of the Medical Intensive Care Unit at Boston VA HCS, and serving as the Associate Program Leader of Inhalation Technology at CIMIT. He has also been the Director of Pulmonary Clinics at Boston VA HCS and an Associate Professor of Medicine at Boston University School of Medicine.

Jussi Saukkonen has contributed significantly to quality improvement and medical care systems redesign, medical education, tuberculosis, and global health initiatives. Moreover, he has been involved in the development of innovative medical technologies like the Low-Cost Ventilator for Developing Countries/Mass Casualty Response, aimed at providing critical care solutions at minimal costs.

With a strong background in clinical trial protocol design, drug development, drug safety, and consulting, Jussi Saukkonen continues to be a prominent figure in the healthcare industry, impacting patient care, research, and medical innovation.